Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures in Pediatric Egyptian Patients

NCT05670509 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05670509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05670509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures in Pediatric Egyptian Patients
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
January 19, 2019
Completion date
July 31, 2022
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convulsions